Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 6, 1999, Pages 1250-1255

  Gordon, Lynn K ^a,b,e   Eggena, Mark ^a,c   Targan, Stephan R ^a,d   Braun, Jonathan ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CILIARY BODY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IRIDOCYCLITIS; PRIORITY JOURNAL; RETINA GANGLION CELL;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGENS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CADAVER; CILIARY BODY; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IRIS; RETINAL GANGLION CELLS;

EID: 0032925338     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mochizuki M, Kuwabara T, McAllister C, Nussenblatt RB, Gery I. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci. 1985;158:1895-1911.
2. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class-II-restricted T lymphocytes. Annu Rev Immunol. 1990;8:773-794.
3. Brandtzaeg P, Bjerke K. Human peyer's patches: lympho-epithelial relationships and characteristics of immunoglobulin-producing cells. Immunol Invest. 1989;18:29-45.
4. Pugliesi, A, Eisenbarth, GS. Type 1 diabetes mellitus: lessons for human autoimmunity. J Lab Clin Med. 1992;120:363-366.
5. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan R. Antineutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology. 1991;100:1590-1596.
6. Yang H, Rotter JI, Toyoda H, Landers C, Tyan DM, Targan SR. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest. 1993;92:1080-1084.
7. Berberian LS, Valles-Ayoub Y, King L, Gordon LK, Braun J. Expression of a novel autoantibody defined by the VH3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis. J Immunol. 1994;153:3756-3763.
8. Braun J, Valles-Ayoub Y, Berberian L, Eggena M, Gordon LK, Targan SR. On the pathogenesis trail: what marker B cell clones tell us about inflammatory bowel disease. Can J Gastroenterol. 1996; 10:115-119.
9. Hagen EC, van de Vijver-Reenaldo H, de Keizer RJ, et al. Uveitis and anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol. 1994;95:56-59.
10. Saxon A, Shanahan F, Landers C, Ganz T, Targan SR. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86: 202-210.
11. Gordon LK, Eggena M, Hollanad GN, Weisz JM, Braun J. pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol. 1998;18:264-271.
12. Billing P, Tahir S, Calfin B, et al. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol. 1995;147:979-987.
13. Vidrich A, Lee J, James E, Cobb L, Targan S. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol. 1995;15:293-299.
14. Sandborn WJ, Landers CJ, Steiner BL, Tremaine NJ, Targan SR. Association of antineutrophil cytoplasmic antibody is unexpectedly high in patients with treatment resistant, left-sided ulcerative colitis. Mayo Clin Proc. 1996;71:431-436.
15. Sandborn WJ, Landers CJ, Steiner BL, Tremaine NJ, Targan SR. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal-anal pouch anastomosis. Am J Gastroenterol. 1996;90:740-747.
16. Shanahan F, Duerr R, Landers C, Yang H, Sutherland L, Rotter JT. Neutrophil autoantibodies in ulcerative colitis: a family study with evidence for genetic heterogeneity. Gastroenterology. 1992;103: 456-461.
17. Seibold R, Slameschka D, Gregor M, Weber F. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1994;107:532-536.
18. Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol. 1997;115:61-64.
19. Soukiassian SH, Foster CS, Raiman MB. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol. 1994;118:601-611.
20. Banares AA, Jover JA, Fernandez-Gutierrez B, et al. Bowel inflammation in anterior uveitis and spondyloarthropathy. J Rheumatol. 1995;22:1112-1117.
21. Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol. 1996;156:4005-4011.
22. Barbas CF, Kang AS, Lerner R, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA. 1991;88:7978-7982.
23. Cuevas EC, Bateman AC, Wilkins BS, et al. Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol. 1994;47:448-452.
24. Taylor CR, Shi SR, Chaiwun B, Young L, Iman SA, Cote RJ. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol. 1994;25:263-270.
25. Sobajima J, Ozaki S, Uesugi H, et al. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) directed against HMG1 and HMG2 in ulcerative colitis. Clin Exp Immunol. 1998;111:402-407.
26. Parseghian MH, Henschen AH, Krieglstein KG, Hamkalo BA. A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. Protein Sci. 1994;3:575-587.
27. Liao L, Singhwani R, Rojkind M, Factor S, Leinwand L, Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med. 1995;181: 1123-1131.
28. Zhao Z-S, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 1998;279:1344-1347.
29. Forrester JV, Liversidge J, Dick A, et al. What determines the site of inflammation in uveitis and chorioretinitis. Eye. 1997;11:162-166.
30. McMenamin PG. The distribution of immune cells in the uveal tract of the normal eye. Eye. 1997;11:183-193.
31. Broekhuyse RM, Kuhlmann ED, Winkens HJ, Van Vugt AHM. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis, I: induction by a detergent-insoluble, intrinsic protein fraction of the retinal pigment epithelium. Exp Eye Res. 1991;52:465-474.
32. Prendergast RA, Iliff CE, Coskuncan NM, et al. T-cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1998;39:752-762.
33. Butler TL, McMenamin PG. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1996;37: 2195-2210.